Search research articles
Contact Us
Filters
Showing results (101-110 of 135) with videos related to
Page
of 14
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
November 19, 2013
Hypercapnia affects the functional coupling of resting state electroencephalographic rhythms and cerebral haemodynamics in healthy elderly subjects and in patients with amnestic mild cognitive impairment
Claudio Babiloni, Fabrizio Vecchio, Riccardo Altavilla, et al.
The Journal of Headache and Pain
|
April 28, 2022
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
The Journal of Headache and Pain
|
June 7, 2022
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
December 31, 2014
Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity
Doriana Landi, Paola Maggio, Domenico Lupoi, et al.
Experimental Neurology
|
February 13, 2007
fMRI-vs-MEG evaluation of post-stroke interhemispheric asymmetries in primary sensorimotor hand areas
Claudia Altamura, Kahtya Torquati, Filippo Zappasodi, et al.
The Journal of Headache and Pain
|
April 10, 2022
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Headache
|
December 18, 2020
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Journal of Neurology
|
June 25, 2021
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura
Claudia Altamura, Angelo Cascio Rizzo, Giovanna Viticchi, et al.
Headache
|
July 26, 2021
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
Piero Barbanti, Cinzia Aurilia, Sabina Cevoli, et al.
Journal of Clinical Neurology (Seoul, Korea)
|
April 14, 2016
Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia
Claudia Altamura, Federica Scrascia, Carlo Cosimo Quattrocchi, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 135) with videos related to
Sort By:
Page
of 14
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
November 19, 2013
Hypercapnia affects the functional coupling of resting state electroencephalographic rhythms and cerebral haemodynamics in healthy elderly subjects and in patients with amnestic mild cognitive impairment
Claudio Babiloni, Fabrizio Vecchio, Riccardo Altavilla, et al.
The Journal of Headache and Pain
|
April 28, 2022
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
The Journal of Headache and Pain
|
June 7, 2022
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
December 31, 2014
Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity
Doriana Landi, Paola Maggio, Domenico Lupoi, et al.
Experimental Neurology
|
February 13, 2007
fMRI-vs-MEG evaluation of post-stroke interhemispheric asymmetries in primary sensorimotor hand areas
Claudia Altamura, Kahtya Torquati, Filippo Zappasodi, et al.
The Journal of Headache and Pain
|
April 10, 2022
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Headache
|
December 18, 2020
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Journal of Neurology
|
June 25, 2021
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura
Claudia Altamura, Angelo Cascio Rizzo, Giovanna Viticchi, et al.
Headache
|
July 26, 2021
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
Piero Barbanti, Cinzia Aurilia, Sabina Cevoli, et al.
Journal of Clinical Neurology (Seoul, Korea)
|
April 14, 2016
Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia
Claudia Altamura, Federica Scrascia, Carlo Cosimo Quattrocchi, et al.
Page
of 14